The Shared Bulletin Board
All Bulletins
-
- Press Releases Gene Editing Patent
-
C4U and Jichi Medical University Enter Into an Agreement on Co-Ownership of a Patent Right Posted on: July 27, 2026 Author: Ｃ４Ｕ株式会社
-
- Press Releases Infectious Diseases
-
GHIT Fund Invests Approx. JPY 140 Million in a Portable Rapid Diagnostic System for Ebola Disease in a Joint Project Between Osaka Metropolitan University, K.K. DNAFORM, and INRB Posted on: July 23, 2026 Author: Global Health Innovative Technology Fund (GHIT Fund)
-
- Press Releases Infectious Diseases Research ＆ Development
-
Japan convenes global leaders in malaria research and development to strengthen partnerships for innovative prevention and treatment tools Posted on: July 22, 2026 Author: Global Health Innovative Technology Fund (GHIT Fund)
-
- Events India Market research Event Date: Deadline:
-
[7/27 Hybrid](India) Medical Excellence India Research Debriefing: Registration open! Posted on: July 17, 2026 Author: 一般社団法人Medical Excellence JAPAN
-
- Press Releases Infectious Diseases Drug Development
-
Total Investment of Approx. USD 18 Million in Malaria, Tuberculosis and NTD R&D Projects with Partners Including Shionogi, Eisai, Nagasaki, Ehime and Niigata University Posted on: July 13, 2026 Author: 公益社団法人グローバルヘルス技術振興基金
-
- Press Releases Gene Editing
-
A Divisional Patent of CRISPR-Cas3 Basic Patent Issued in Japan (Patent No. 7886063) Posted on: July 8, 2026 Author: Ｃ４Ｕ株式会社
-
- Events Funding Event Date: Deadline:
-
【Call for Participants!】Financial Strategies for Early-Stage Biotech Companies Posted on: June 22, 2026 Author: 川崎市産業振興財団
-
- Press Releases Infectious Diseases
-
GHIT Fund Kick-Started Emergency Product Development Support for Ebola Disease Outbreak Caused by Bundibugyo Virus Posted on: June 17, 2026 Author: Global Health Innovative Technology Fund (GHIT Fund)
-
- News & Activities Vaccine Drug Development
-
FunPep Co., Ltd. and Crafton Biotechnology Co., Ltd. Enter into Joint Research Agreement for Therapeutic mRNA Vaccines — Combining Antibody-Inducing Peptide Technology with Proprietary mRNA Technology Posted on: June 1, 2026 Author: Crafton Biotechnology株式会社
-
- Press Releases Gene Editing Drug Discovery
-
C4U Completed the AMED Stage-Gate Evaluation for Stage 2 Posted on: May 29, 2026 Author: Ｃ４Ｕ株式会社
-
- Press Releases Biotechnology Pharmaceuticals Nucleic Acid Medicine Industry-academia collaboration
-
Crafton Biotechnology Enters into an Agreement for the Manufacturing and Commercialization of a Novel Phosphoramidite Reagent to Enable High‑Purity mRNA Synthesis Posted on: May 18, 2026 Author: Crafton Biotechnology株式会社
-
- Press Releases Gene Editing
-
CRISPR-Cas3 Basic Patent Issued in Europe (European Patent No. 3950942) Posted on: April 30, 2026 Author: C4U Corporation
This message board is for LINK-J members and partners with LINK-J. Please click here for guidelines, terms and conditions.